SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about newspaper advertisements

01 Feb 2026 Evaluate
Sun Pharmaceutical Industries has informed that the Company has published newspaper advertisements [All editions of Financial Express (in English) and Vadodara Edition of Loksatta Jansatta (in Gujarati)] on 01 February 2026, containing information about the Unaudited Financial Results for the quarter and nine months ended 31 December 2025. Copies of newspaper clippings, which are attached as Annexure-A, are also available on the Company’s website at www.sunpharma.com.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma. Inds. Share Price

1952.45 12.30 (0.63%)
15-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1952.45
Dr. Reddys Labs. 1229.80
Cipla 1437.95
Lupin 2491.80
Zydus Lifesciences 1154.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: